Mammographic breast density was inversely associated with ODxRS (P  .05). Average ODxRS for density category A was 24.4 and that for density category D was 16.5 (P , .02). Both indistinct mass margins and fine linear branching calcifications at mammography were significantly associated with higher ODxRS (P , .01 and P , .03, respectively). Masses with indistinct margins had an average ODxRS of 31.3, which significantly differed from the ODxRS of 18.5 for all other mass margins (P , .01). The average ODxRS for fine linear branching calcifications was 29.6, whereas the ODxRS for all other suspicious calcification morphologies was 19.4 (P , .03). Average ODxRS was significantly higher for irregular mass margins at MR imaging compared with spiculated mass margins (24.0 vs 17.6; P , .02). The presence of nonmass enhancement at MR imaging was associated with lower ODxRS than was its absence (16.4 vs 19.9; P , .05).
Purpose:
To evaluate the association between Breast Imaging Reporting and Data System (BI-RADS) mammographic and magnetic resonance (MR) imaging features and breast cancer recurrence risk in patients with estrogen receptor-positive breast cancer who underwent the Oncotype DX assay.
Materials and Methods:
In this institutional review board-approved and HIPAAcompliant protocol, 408 patients diagnosed with invasive breast cancer between 2004 and 2013 who underwent the Oncotype DX assay were identified. Mammographic and MR imaging features were retrospectively collected according to the BI-RADS lexicon. Linear regression assessed the association between imaging features and Oncotype DX test recurrence score (ODxRS), and post hoc pairwise comparisons assessed ODxRS means by using imaging features.
Results:
Mammographic breast density was inversely associated with ODxRS (P  .05). Average ODxRS for density category A was 24.4 and that for density category D was 16.5 (P , .02). Both indistinct mass margins and fine linear branching calcifications at mammography were significantly associated with higher ODxRS (P , .01 and P , .03, respectively). Masses with indistinct margins had an average ODxRS of 31.3, which significantly differed from the ODxRS of 18.5 for all other mass margins (P , .01).
The average ODxRS for fine linear branching calcifications was 29.6, whereas the ODxRS for all other suspicious calcification morphologies was 19.4 (P , .03). Average ODxRS was significantly higher for irregular mass margins at MR imaging compared with spiculated mass margins (24.0 vs 17.6; P , .02). The presence of nonmass enhancement at MR imaging was associated with lower ODxRS than was its absence (16.4 vs 19.9 ; P , .05).
Conclusion:
The BI-RADS features of mammographic breast density, calcification morphology, mass margins at mammography and MR imaging, and nonmass enhancement at MR imaging have the potential to serve as imaging biomarkers of breast cancer recurrence risk. Further prospective studies involving larger patient cohorts are needed to validate these preliminary findings.
lymph node-negative breast cancer (11, 12) . The majority of previous studies that explored the association between breast imaging phenotypes and gene expression profiles in the context of recurrence risk focused on quantitative magnetic resonance (MR) imaging features (13) (14) (15) (16) . Two prior studies assessed the association between qualitative Breast Imaging Reporting and Data System (BI-RADS) mammographic and MR imaging descriptors used in daily clinical practice and Oncotype DX, a molecular assay of recurrence risk, in patients with ERpositive cancers (17, 18) . Prior singleinstitution studies found no relationship between mammographic breast density or nonmass enhancement (NME) at MR imaging and recurrence risk; however, differences in cohort selection, smaller sample sizes for various imaging features, and failure to control for potential confounders such as age, body mass index, menopausal status, or prior history of breast cancer may have influenced these investigators' results.
The purpose of our exploratory study was to evaluate the association between BI-RADS mammographic and MR imaging features and breast cancer recurrence risk in patients with standard of care, would add significant clinical value. Because imaging can noninvasively characterize the entire tumor in vivo, it can better depict the heterogeneity of breast cancers, which may be missed by other approaches that rely on selective tissue sampling, including genomic assays (5-7). Imaging studies may thereby yield information that is complementary to molecular analysis.
Oncotype DX (Genomic Health, Redwood City, Calif) is a prospectively validated 21-gene expression assay that estimates the 10-year risk of distant recurrence and also predicts the magnitude of chemotherapy benefit in women with estrogen receptor (ER)-positive, lymph node-negative breast cancer who are treated with tamoxifen (8, 9) . This subgroup of women encompasses approximately half of all patients with breast cancer. The likelihood of distant recurrence in this patient cohort is not well defined by using clinical or histopathologic measures, which has historically hampered the ability to select appropriate candidates for chemotherapy (10) 
Advances in Knowledge
n Mammographic breast density category A (almost entirely fatty) was associated with an intermediate risk of recurrence, significantly higher compared with that of breast density category D (extremely dense), which was associated with a low risk of recurrence.
n Both indistinct mass margins and fine linear branching calcifications had significantly higher recurrence scores compared with those of all other mass margins and suspicious calcification morphologies.
n Irregular mass margins at MR imaging were associated with higher recurrence scores compared with those of spiculated mass margins.
n Women with nonmass enhancement (NME) present at MR imaging had lower recurrence scores compared with those of women without NME. With respect to MR imaging, a total of 252 women did not undergo an MR imaging examination and an additional 60 MR imaging reports were not in the electronic medical records. Also excluded from the data set of MR imaging examinations were studies with substantial changes after biopsy or surgery limiting evaluation (n = 7) and substantial biopsy clip susceptibility artifact obscuring the primary finding (n = 2), resulting in a total of 229 MR images available for data analysis.
Demographic data, including patient age, body mass index, parity, menopausal status, hormone use, personal history of prior invasive breast malignancy or ductal carcinoma in situ (DCIS), BRCA gene mutation status, and family history of breast cancer were gathered from the electronic medical records. Invasive malignancy type (ductal, lobular, or mixed), presence of DCIS, histologic grades, receptor status (ER, progesterone receptor, human epidermal growth factor receptor 2), and lymph node status were obtained from pathologic reports. If the pathologic report gave a range of grades for the invasive malignancy or DCIS, then the highest grade was recorded.
Oncotype DX Test Recurrence Score Women identified for this study underwent Oncotype DX tumor profiling at the time of diagnosis. The Oncotype DX assay calculates a woman's risk of distant disease recurrence in the next 10 years and categorizes it into three risk levels: low (score ,18), intermediate (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , and high (31) (8) . These three categories correspond to an estimated Oncotype DX test recurrence score (ODxRS) of 6.8%, 14.3%, and 30.5%, respectively.
Mammographic and MR Imaging Features
Mammographic and MR imaging descriptive features were retrospectively recorded according to the 2013 edition of the American College of Radiology BI-RADS lexicons (19) . Older BI-RADS terms that were retired from ER-positive breast cancer who underwent the Oncotype DX assay.
Materials and Methods

Study Population
By using an institutional review boardapproved and Health Insurance Portability and Accountability Act-compliant protocol, all women who were seen at our institution with invasive breast carcinoma between 2004 and 2013 and underwent a successful Oncotype DX assay at the time of diagnosis were identified (n = 556). From our breast cancer registry data, 509 of these 556 patients received their care at our institution. The remaining 47 patients had imaging and pathologic records uploaded into our electronic medical records, but were consults only with treatment received elsewhere (n = 44) or treatment received at our institution for a different type of cancer (n = 3). Among the 3888 patients treated for invasive breast carcinoma at our institution between 2004 and 2013, 13% (n = 509) had an Oncotype DX assay ordered by the treating physician. Our surgeons and oncologists order an Oncotype DX assay to help them determine the benefit of chemotherapy among women with an intermediate pretest probability of chemotherapy benefit based on clinical and pathologic factors.
The biopsy specimen that was sent for Oncotype DX testing was considered the primary lesion in the case of multifocal disease. If two Oncotype DX assays were performed in the same participant, then the lesion that was of palpable concern or documented first in the diagnostic mammogram report was selected for analysis to ensure independent sampling. Six patients were excluded from the analysis because they had bilateral disease and the medical records did not designate the laterality of the tumor that was submitted for the Oncotype DX assay.
For the remaining 550 women, 408 had any breast imaging (mammogram and/or MR imaging) reports from both our own institution and outside facilities available for data collection. With respect to mammography, a total of BREAST IMAGING: Qualitative Radiogenomics Woodard et al tumor status (n = 3) were conducted because the Oncotype Dx assay was originally validated in a population of ER-positive women (8) . Additionally, square-root transformed for linear regression to assess the normality of the residuals. Final regression and analysis of variance models are presented with nontransformed data because the direction and magnitude of the beta coefficients, means, and P values did not significantly differ, and transformations can alter the fundamental nature of the data and make interpretation challenging (21, 22) . To avoid multicollinearity, age and menopausal status were not included together in regression models. The association between mammographic breast density and ODxRS was first adjusted for age and further stratified by using menopausal status to avoid confounding. Robustness models excluding women with ER-negative morphology and distribution; and mass shape, margin, and enhancement at MR imaging), linear regression modeling was chosen over logistic regression modeling by using a stratified ODxRS (low, intermediate, and high) to increase the power to reject the null hypothesis (20) . To reduce the type I error rate but not increase the type II error rate, only univariate regression models that were statistically significant (P  .05) were considered imaging features of interest and tested in multivariable regression models. Subsequently, post hoc pairwise comparisons of ODxRS means by imaging features of interest were assessed by using one-way analysis of variance and Tukey test for multiple comparisons. Nonnormally distributed independent and dependent variables were log-or Note.-Unless otherwise indicated, data are raw data, with percentages in parentheses. Characteristics with denominators less than 408 were because of missing data. HRT = hormone replacement therapy. OCP = oral contraceptives.
* Data in parentheses are means 6 standard deviation.
BREAST IMAGING: Qualitative Radiogenomics Woodard et al and calcification morphology were significantly associated with ODxRS. Mammographic breast density was inversely associated with ODxRS (P , .01). When adjusted for age, prior history of disease, and body mass index, the association remained significant (P  .05). Both indistinct mass margins (Fig 1) and fine linear branching calcification morphology (Fig 2) were positively associated with a higher ODxRS (adjusted P , .01 and P , .03, respectively). The MR imaging features that were significantly associated with ODxRS were mass shape, mass margins, and the presence of NME (as the primary finding or associated with a mass). Round mass shape at MR imaging was associated with a higher ODxRS (P , .01); however, this association appeared to be secondary to the single outlier (ODxRS, 82). When the outlier was excluded from the small sample size with round mass shape, the association was no longer observed (n = 5; P , .6) ( Table E2 [online]) and therefore was not considered a robust association. Irregular mass margins at MR imaging were associated with higher ODxRS, whereas spiculated mass margins at MR imaging were associated with lower ODxRS (adjusted P , .01 and P , .03, respectively). The presence of NME was inversely associated with ODxRS (adjusted P , .05). Average ODxRS was calculated only for BI-RADS mammographic and MR imaging features that were statistically significant in univariate linear regression models. The mean ODxRS for mammographic breast density category A was 24.4 and that for breast density category D was 16.5, corresponding to an intermediate risk of recurrence (ROR) for density category A versus a low ROR for density category D (P , .02) (Fig 3) . These means remained significantly different when adjusted for age, body mass index, and prior history of breast cancer (adjusted P , .02). Mean ODxRS also varied among mammographic mass margins and calcification morphology (Figs 4, 5 
Results
Descriptive data for participant and tumor characteristics are reported in Table 1 . The average age at diagnosis was 53.3 years. Approximately half of women were pre-or perimenopausal (51.4%) and just over 10% of women had a prior history of breast cancer. As expected, the majority of invasive carcinomas were predominantly ductal type (83.1%) and histologic grades I and II (27.6% and 58.1%, respectively). In keeping with the originally described criteria for use of ODxRS, most of the cancers were ER positive (99.3%) and human epidermal growth factor receptor 2 negative (95.5%).
The descriptive mammographic and MR imaging features for the cohort are presented in Tables 2 and 3 . As expected, the most common mammographic breast density category was scattered (35%) or heterogeneously dense (42%). The mammographic manifestation of breast cancer was a suspicious mass in approximately 45% of women and suspicious calcifications in approximately 33% of women. Among these women, 12% presented with the combination of a suspicious mass and suspicious calcifications. Among the MR imaging features, a mass was present in over 90% of women and nearly onethird of women had NME present (n = 73). NME was the primary finding in 42% of women and was associated with a mass in 58% of women.
The association between BI-RADS imaging features and ODxRS was assessed by using univariate and multivariable linear regression (Table 4) . Because both age and prior history of breast cancer were significantly associated with ODxRS in univariate analyses, they were considered potential confounders and were adjusted for in multivariable models. Body mass index was considered an additional confounder for breast density and fibroglandular tissue models.
Among the mammographic features, breast density, mass margins, because there was an outlier ODxRS of 82, which was greater than 5 standard deviations above the mean ODxRS for the whole cohort, robustness models excluding this extreme value were completed. (See Tables E1-E4 [online] for these results).
All statistical analyses were completed by using SAS University Edition (version 9.4; Cary, NC). Two-sided P (Fig 6) . Lastly, patients without NME had an average ODxRS of 19.9, whereas patients with NME had an average ODxRS of 16.4, corresponding to an intermediate and low ROR, respectively (Fig 7) . These means remained significantly different when adjusted by age and prior history of disease (P , .05). A multivariable regression model including age, prior history of breast cancer, body mass index, invasive tumor grade, DCIS tumor grade, and ER status was performed to evaluate the added effect of the five significant BI-RADS mammographic and MR imaging features. Both indistinct mass margins and fine linear branching calcifications at mammography and the absence of NME at MR imaging remained significantly associated with higher ODxRS (P , .001, P , .01, and P , .05, respectively). The R-squared value for the regression model increased from 0.34 to 0.55 when the five imaging features were included.
In univariate and multivariable linear regression models, mammographic breast density was only significantly associated with ODxRS among postmenopausal women (unadjusted P , .02; adjusted P , .04). Pre-and perimenopausal women had an average ODxRS of 12.4 for breast density category A and 16.7 for density category D (unadjusted P , .4; adjusted P , .9). Postmenopausal women and those with breast density category A had an average ODxRS of 25.6, and those with breast density category D had an average score of 16.6 (unadjusted P , .05; adjusted P , .2). * Data in parentheses are 95% confidence intervals. † Linear regression models assessing the association between imaging features and ODxRS in multivariable models adjusted for age and personal history of invasive carcinoma or DCIS. Both mammographic breast density and fibroglandular tissue models were further adjusted by body mass index.
BREAST IMAGING: Qualitative Radiogenomics Woodard et al with less favorable prognosis in patients with breast cancer. Masarwah et al found very low breast density to be an independent predictor of decreased survival over a 12-year follow-up period in a cohort of 270 women aged 32-86 years (25) . A Denmark cohort study of women aged 50-69 years noted increased survival among women with mixed breast density compared with those with fatty breasts (10) . In addition, a Breast Cancer Surveillance Consortium study observed higher death rates from breast cancer among women with low breast density who had obesity (26, 27) . A proposed biologic mechanism underlying this increased prognostic risk in women with fatty breasts is the deregulation of adipose tissue signaling pathways within the breast microenvironment, leading to local aromatization of androgens to estrogens that may promote tumor recurrence (27, 28) . Interestingly, when we and mammographic breast density, indistinct mass margin and fine linear branching calcifications at mammography, irregular and spiculated mass margins at MR imaging, and NME at MR imaging by using models adjusted for potential clinical confounders. We found that lower mammographic breast density was associated with higher recurrence risk. This association remained significant after adjustment for body mass index. Although increased breast density is a known risk factor for breast cancer (23, 24) , the association between breast density and prognosis is not as well established. Dialani et al did not observe a significant difference in the mean ODxRS across the four breast density groups, although no adjustments were made for body mass index or menopausal status (17) . In keeping with our findings, some evidence indicates that low breast density may be associated Secondary analyses were conducted to assess the robustness of the final results (see Tables E1-E4 [online]). Results were similar in magnitude and direction in linear regression models and post hoc pairwise comparison. Because the maximum value for ODxRS was 82, greater than 5 standard deviations above the mean ODxRS for the whole cohort, analyses were repeated excluding this single value and again produced similar results.
Discussion
The goal of this retrospective exploratory study was to identify BI-RADS mammographic and breast MR imaging features that are associated with breast cancer recurrence risk by using ODxRS as a surrogate marker for risk. We observed statistically significant associations between ODxRS 
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Woodard et al the highest ODxRS and were all grades II or III. Although both indistinct and spiculated margins are considered suspicious features according to the BI-RADS lexicon, the latter have been shown to be associated with a more favorable prognosis (29, 30 ). In contrast, Shin et al found that indistinct mass margins were associated with higher histologic grade and extensive intraductal component (31) . Although indistinct margins were associated with ER-negative status in that study, our findings remained robust after excluding the few ER-negative cancers in secondary analysis. Similarly, irregular mass margins at MR imaging had a significantly higher ODxRS compared with that of spiculated margins at MR imaging. The indistinct mass margins at mammography and irregular mass margins at MR imaging may be indicative of a more aggressive malignancy, whereas spiculated margins may suggest a more indolent growth pattern that incites a desmoplastic reaction. This proposed mechanism of tumor growth was also discussed by Dialani et al, who noted a higher ODxRS among masses with an oval shape (which is often considered a more benign morphology at mammography). Yepes et al did not observe an association between mass margins and ODxRS, although a smaller sample size for their mass margins may have reduced their power to detect a difference (18) . We also found fine linear branching calcification morphology to be independently associated with a higher ODxRS. Fine linear branching calcifications have been shown to be associated with highgrade, poorly differentiated DCIS and DCIS of the comedo type, which are subtypes that have been shown to be associated with higher recurrence rates (32, 33) . In addition, studies have found that the presence of fine linear branching calcification is a poor prognostic factor in small screening-detected invasive cancers (29, 34, 35) . Yepes et al found an association between fine pleomorphic calcifications and higher ODxRS in their study of 97 women (18) . However, Dialani et al did not observe an association between ODxRS and calcification postmenopausal cohort relates to the long-term effects of low breast density or the more proximate effects of fatty involution after menopause.
In our cohort, masses with indistinct margins at mammography had stratified patients by using menopausal status, the association between low breast density and elevated recurrence risk remained significant only among postmenopausal women. It is uncertain whether this elevated risk in the Bar chart shows average ODxRS by using mammographic breast density. * = Breast density category A versus density category D; P value adjusted by age at detection, body mass index, and personal history of invasive carcinoma or DCIS. ROR: low (score ,18), intermediate (score [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , and high (score 31).
Woodard et al of an association for the presence of a mass at MR imaging and ODxRS in regression modeling, our significant finding with NME may arise from different analytic methods and more observed cases of NME. Although demonstrating significant associations, the five BI-RADS imaging features (mammographic breast density, calcification morphology, mass margins at mammography and MR imaging, and NME at MR imaging) are less than perfect predictors of recurrence risk. However, when combined with other demographic and clinical factors, there was improvement in the multivariable regression model showing an association with ODxRS. This finding supports the added clinical value of using imaging features to predict not only the presence of malignancy, but also to potentially aid in its prognosis.
The retrospective design of this exploratory study had several limitations. First, the mammographic and MR imaging features were collected from the imaging reports rather than reinterpreted, and they were collected during a date range in which the BI-RADS lexicon version changed. Furthermore, because the breast imaging was interpreted at multiple institutions, there is inherent variability among radiologist interpretations. Because the radiologists were not blinded to ODxRS, we cannot exclude this potential source of reader bias. Another limitation of our study was the small sample size. Several of the BI-RADS descriptors were not reported in multiple cases, reducing the sample size for several imaging features (especially mass shape and margin, calcification morphology, and enhancement at MR imaging). Given the small sample size of many imaging features, linear regression modeling was chosen over logistic regression. Additionally, because exploratory studies have inherently higher rates of false-positive results, future prospective studies with larger samples sizes would provide more statistical power to answer whether hypothesized breast imaging features can categorize women into recurrence risk categories, as determined by the genomic profile. Our study was also potentially limited by selection often associated with the presence of DCIS, which has a lower risk of distant recurrence than invasive cancer (36) (37) (38) . Jiang et al found that the presence of NME was correlated with invasive tumors of lower histologic grade, although invasive tumor grade did not differ significantly between women with and women without NME in our study (36) . Dialani et al did not find a difference in the average ODxRS for invasive breast carcinoma manifesting as a mass compared with those manifesting as NME. Although we confirm the lack morphology (17) . The reported association between calcification morphology and recurrence may differ based on which tumor characteristics were evaluated, because Yepes et al did not include any cases of fine linear branching morphology and Dialani et al did not include any cases of coarse heterogeneous calcifications in their cohorts.
Lastly, the presence of NME was significantly associated with lower ODxRS. This observation is in line with previous studies showing that compared with mass lesions, NME is more 
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Figure 6
Figure 6: Bar chart shows average ODxRS by using mass margins at MR imaging. * = Irregulars mass margins versus spiculated mass margins; P value adjusted by age at detection and personal history of invasive carcinoma or DCIS. ROR: low (score ,18), intermediate (score [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , and high (score 31).
Figure 7
Figure 7: Bar chart shows average ODxRS by using NME at MR imaging. * = Absence of NME at MR imaging versus presence at NME; P value adjusted by age at detection and personal history of invasive carcinoma or DCIS. ROR: low (score ,18), intermediate (score [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , and high (score 31).
bias. At our institution, the Oncotype DX assay is used in clinical practice to help determine the benefit of chemotherapy among women with early-stage ER/progesterone receptor-positive, human epidermal growth factor receptor 2-negative, and lymph node-negative breast cancer with an intermediate pretest probability of chemotherapy benefit based on clinical and pathologic factors. Among the 3888 women with invasive breast carcinoma treated at our institution from 2004 to 2013, approximately 13% underwent the Oncotype DX assay. Therefore, our study results may not be generalizable to women with either an existing high pretest probability of chemotherapy benefit (ie, high tumor grade, large tumor size, or young age) or low pretest probability (ie, small tumor size, advanced age, or severe comorbidities), because such patients were likely to be underrepresented in our study. Finally, although validated, the ODxRS is a surrogate marker of breast cancer recurrence risk and surrogates are imperfect. To determine the true relationship between BI-RADS imaging features and recurrence risk, future studies should include follow-up data on disease recurrence. Because the Oncotype DX assay is performed by using a limited tissue sample of the malignancy, whereas breast imaging captures information from the entire tumor in vivo, imaging may ultimately provide additional prognostic information that is complementary to genomic assays.
In conclusion, this exploratory work demonstrates that descriptive BI-RADS features including mammographic breast density, calcification morphology, mass margins at mammography and MR imaging, and NME at MR imaging have the potential to serve as imaging biomarkers of breast cancer recurrence risk, and therefore may help to guide tailored treatment strategies. Because breast imaging is routinely obtained for clinical care, the ability to extract prognostic information from diagnostic imaging studies would add substantial clinical value. These findings supplement the current literature and lay the groundwork for future larger prospective studies, which are needed to validate our preliminary observations. 
